Loading...
Loading...
American Eagle Outfitters
AEO is expected to report its Q2 earnings at $0.21 per share on revenue of $721.68 million.
Hewlett-Packard Company
HPQ is projected to post its Q3 EPS at $0.98 on revenue of $30.10 billion.
Chico's FAS
CHS is estimated to report its Q2 EPS at $0.30 on revenue of $641.26 million.
Express
EXPR is projected to report its Q2 earnings at $0.17 per share on revenue of $467.43 million.
Toll Brothers
TOL is estimated to report its Q3 EPS at $0.18 on revenue of $508.98 million.
Pacific Sunwear of California
PSUN is projected to post a Q2 loss at $0.12 per share on revenue of $203.17 million.
Guess'
GES is expected to post its Q2 earnings at $0.54 per share on revenue of $637.19 million.
Synopsys
SNPS is estimated to post its Q3 EPS at $0.50 on revenue of $443.94 million.
China Cord Blood
CO is projected to post its Q1 earnings at $0.04 per share on revenue of $16.23 million.
Focus Media Holding Ltd
FMCN is estimated to post its Q2 EPS at $0.59 on revenue of $225.98 million.
Krispy Kreme Doughnuts
KKD is projected to post its Q2 EPS at $0.05 on revenue of $103.74 million.
Prospect Capital
PSEC is estimated to post its Q4 earnings at $0.40 per share on revenue of $85.12 million.
Vanguard Health Systems
VHSLoading...
Loading...
is projected to post its Q4 EPS at $0.12 on revenue of $1.53 billion.
HEICO
HEI is expected to post its Q3 EPS at $0.41 on revenue of $232.25 million.
The Hain Celestial Group
HAIN is projected to post its Q4 EPS at $0.45 on revenue of $365.59 million.
Semtech
SMTC is estimated to post its Q2 EPS at $0.41 on revenue of $149.56 million.
China Zenix Auto International Ltd
ZX is expected to report its Q2 earnings.
Eaton Vance
EV is projected to report its Q3 earnings at $0.47 per share on revenue of $304.06 million.
International Rectifier
IRF is estimated to post a Q4 loss at $0.15 per share on revenue of $262.53 million.
DFC Global
DLLR is expected to post its Q4 EPS at $0.56 on revenue of $281.18 million.
Delhaize Group
DEG is estimated to report its Q2 earnings.
China Nuokang Bio-Pharmaceutical
NKBP is expected to post its Q2 earnings at $0.07 per share on revenue of $11.81 million.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in